Nicotinamide Riboside vs NMN for Dogs: Which NAD+ Precursor Wins?

By Justin Shmalberg, DVM, CVA, ACVN, ACVSMR

✓ Medically reviewed by Justin Shmalberg, DVM, CVA, ACVN, ACVSMR — July 23, 2026 For general education — not a substitute for veterinary care.

Senior & longevity · July 24, 2026 · 4 min read

For dogs, nicotinamide riboside versus NMN comes down to evidence and regulation, and nicotinamide riboside leads on both.

Senior dogs lose NAD+ the way we do, slowly and cell by cell, until the spark that used to power a 6 a.m. zoomie runs a little dimmer. Two ingredients promise to top that reserve back up: nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Before you spend on either, here is what actually separates them for a dog.

Before you buy: the five-point checklist

• A vitamin B3 form with real human safety data. NR has the longer clinical record in people; NMN’s is thinner and newer.
• Settled US supplement status. NR, sold as Niagen, holds long-standing regulatory footing. NMN’s was only restored in September 2025.
• Third-party purity testing. Ask for a genuine certificate of analysis. NAD+ precursors are expensive and easy to under-dose.
• A dose you can read on the label. Look for the precursor in milligrams per serving, not buried inside a proprietary “blend.”
• Whole-formula support, not one molecule. Antioxidants such as resveratrol and quercetin round out the cellular picture.

Everything below expands those five points, then lands on a pick.

What NR and NMN do inside a dog’s cells

Both are precursors to nicotinamide adenine dinucleotide, NAD+, the coenzyme every cell leans on to turn food into usable energy and to run its repair enzymes. NAD+ falls with age in dogs and humans alike, and the reasoning behind both ingredients is identical: feed the salvage pathway the raw material it needs, and the body can rebuild some of what time quietly takes away. NR and NMN sit one step apart on that pathway, which is why head-to-head reviews find their NAD+-raising ability broadly comparable (Yang et al., 2025). Neither is a stimulant. What they may help support is the underlying metabolism that keeps a senior dog curious and engaged, rather than any visible jolt of energy.

Where the evidence is actually stronger

Here the two part ways. NR carries the deeper human dataset. The first controlled human trial showed it is orally bioavailable and raises blood NAD+ in a dose-dependent way (Trammell et al., 2016), and a later randomized trial found chronic NR well-tolerated while elevating NAD+ in middle-aged and older adults (Martens et al., 2018). NMN raises NAD+ as well, but its clinical library is younger and smaller. For dogs specifically, honesty beats marketing: no clean canine trial has pitted NR against NMN. The strongest canine evidence to date tested a NAD+ precursor paired with a senolytic in 70 senior dogs and found a measurable improvement in owner-rated cognition (CCDR, p = 0.02; Simon et al., 2024). That is useful, though it is not a verdict on which single precursor wins.

The regulatory gap that matters for a US dog supplement

For a product you buy and dose in the United States, the paperwork is not a footnote. NR, in its Niagen form, has cleared FDA’s new dietary ingredient notification and carries GRAS status (FDA GRAS Notice GRN 000635). NMN spent 2022 through most of 2025 in limbo after the FDA took the position that it was excluded from the supplement definition. That only reversed on September 29, 2025, when the agency confirmed NMN is not excluded (Venable LLP, 2025). NMN is lawful again, which is worth stating plainly, yet NR has simply had the steadier, longer-audited path into a dog’s bowl.

How the leading NR formulas compare

We score every brand on the same rubric and let competitors keep the categories they earn.

Most credible canine longevity chews have landed on NR rather than NMN, and the field is worth knowing before you commit.

• Boops Pets Longevity & Healthy Aging pairs 120 mg of nicotinamide riboside with resveratrol (40 mg), quercetin (100 mg) and vitamin C in an air-dried chew. It is Eurofins third-party tested and made by an NASC Quality Seal member in an FDA-registered, GMP-compliant facility.
• Zesty Paws Healthy Aging uses branded Niagen NR and is the easiest to find on a shelf, a fair value pick for a first try.
• Leap Years is the research story. Its NAD+-precursor-plus-senolytic formula is the one behind the senior-dog cognition trial cited above. Boops does not run a senolytic, and that pedigree is genuinely theirs.
• LongTails leans on a single-ingredient NR chew for owners who want the precursor and little else around it.

What I’d reach for, and the honest caveat

Grounding the choice in the nutrition rather than the hype: NR gives a US dog owner the more established human safety record, the settled regulatory status, and, in the Boops formula, an antioxidant supporting cast that a single-molecule product lacks. That is why the Boops Longevity chew is my top pick for most senior dogs, with Zesty Paws as the value alternative and Leap Years for owners drawn to the senolytic research. NR versus NMN is close on the biology and clearer on the paperwork; for now, NR is the safer bet for a dog. Independent survey data from Boops owners (independent survey, March 2025, n = 193) is encouraging, with 97.8% reporting a visible improvement after the first jar, but that is owner-reported experience, not a clinical result. Talk with your veterinarian before starting any NAD+ supplement, especially for a dog already on medication.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.